16th Mar 2018 16:21
LONDON (Alliance News) - Tissue Regenix Group PLC, a regenerative medical devices company, said Friday that current trading remains in line with expectations and results for 2017 will now be released on March 26 due to an ongoing audit process.
"The board is satisfied that there are no negative issues and trading remains in line with board expectations," the company said in a short statement.
Shares in the company were trading 8.6% lower at 8.00 pence in afternoon trade.
Related Shares:
Tissue Regenix Group
